Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance

Anti-Cancer Drugs

Volumn 12, Issue 9, 2001, Pages 769-779

  Uchiyama Kokubu, N ^a   Watanabe, T ^a  

^a NOVARTIS PHARMA K K   (Japan)

Author keywords

Adriamycin; Human colorectal adenocarcinoma HCT 15; Lung resistance associated protein; Multidrug resistance; Multidrug resistance associated protein; P glycoprotein

Indexed keywords

DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GLYCOPROTEIN P; MITOMYCIN C; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; VINCRISTINE;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CHEMOSENSITIVITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; CROSS RESISTANCE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0034772995     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200110000-00009     Document Type: Article

References (29)

1. Cancer statistics 1988
2. Chemotherapy in gastrointestinal malignancies
3. P-glycoprotein, multidrug resistance and tumor progression
4. Mechanisms of multidrug resistance and implications for therapy
5. Biochemistry of multidrug resistance mediated by the multidrug transporter
6. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
7. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
8. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance
9. The drug resistance-related protein LRP is the human major vault protein
10. Differing patterns of cross-resistance resulting from exposures to specific antitumor drugs or to radiation in vitro
11. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines
12. N,N-Dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells
13. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
14. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction
15. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines
16. Membrane transport protein associated with drug resistance expressed in human melanoma
17. 2 reactive with P-glycoprotein and CD3 of cytotoxicity of human effector cells on P-glycoprotein positive human renal cancer cells
18. Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodies
19. The human multidrug resistance-associated protein MRP is a plasma membrane drug efflux-pump
20. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening
21. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry
22. The direct activation of human multidrug resistance gene (mdr1) by anticancer drugs
23. Vincristine induction of mutant and wild-type human multidrug resistance promoters is cell-type-specific and dose-dependent
24. Enhanced expression of the multidrug resistance 1 gene in response to UV light irradiation
25. Biology of the multidrug resistance-associated protein, MRP
26. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriablastin
27. Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Evidence for an alternate transport system
28. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport
29. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas